Top Health Tech Companies in Dublin (89)
Optum, part of the UnitedHealth Group family of businesses, is a global organization that delivers care, aided by technology to help millions of people live healthier lives. The work you do with our team will directly improve health outcomes by connecting people with the care, pharmacy benefits, data and resources they need to feel their best. Here, you will find...
.jpg)
Optum's Top Stability & Growth Strengths
Strong Revenue Growth: Optum’s consolidated revenue expanded from $253.0B in 2024 to $270.6B in 2025, indicating continued top-line growth. Multi‑year reporting also highlights ongoing increases at the consolidated level even as segment performance diverges.
Diversified Revenue Streams: Performance is spread across three businesses, with Optum Rx delivering substantial gains, Optum Insight growing modestly, and Optum Health contracting. This mix shows pharmacy and technology services helping sustain overall scale despite softness in care delivery.
Cost & Operational Efficiency: Operating performance improved in 2026 as Optum’s operating income rose year over year to about $4B in Q2 alongside reported gains in technology and clinical operations. UnitedHealth also raised its 2026 adjusted EPS outlook, signaling confidence in execution.
InterSystems builds the software that makes complex systems work—reliably, securely, and at scale. For more than 45 years, we’ve been the information engine behind some of the world’s most mission-critical applications in healthcare, government, and business. Our data management, integration, and analytics technologies help organizations connect disparate systems, turn data into insight, and deliver better outcomes. From enabling interoperable healthcare and...
InterSystems's Top Stability & Growth Strengths
Profitability: The company is described as privately held, profitable, and debt-free, indicating a solid financial base. This positioning supports continued investment without reliance on external financing.
Strong Revenue Growth: Revenue is reported above $1 billion with indications of year-over-year increases into 2024 and sustained scale into FY2025, while cloud segments are noted as expanding strongly. These signals point to ongoing top-line momentum.
Market Expansion: Operations span 28 countries with 38 offices serving customers in 80+ countries, alongside recent moves such as a dedicated public-sector subsidiary and added international presence. This footprint suggests continued geographic and channel growth.
At EMA Aesthetics we believe that life is an art and everything we do embraces that art. Our approach is avant-garde designed to challenge the status quo. We focus on combination therapy that enhances aesthetic procedures. Results over sentiment. At EMA Aesthetics we regard customers as our partners. Working together, we provide best-in-class aesthetic solutions that yield beautiful returns and...
FDB (First Databank) creates and delivers the world’s most powerful drug knowledge that ignites, inspires, and illuminates critical medication decisions. We collaborate with our partners to help improve patient safety, operational efficiency, and health outcomes. Our drug databases drive healthcare information systems that serve the majority of hospitals, physician practices, pharmacies, payers, and all other areas of healthcare and are...
ArisGlobal is transforming the way today’s most successful life sciences companies develop breakthroughs and bring new products to market. Our end-to-end drug development technology platform, LifeSphere®, integrates our proprietary cognitive computing engine to automate all core functions of the drug development lifecycle. Designed with deep expertise and a long-term perspective that spans more than 30 years, LifeSphere® boosts efficiency, ensures...
.png)
MedModus™ provide comprehensive cloud-based BI, performance improvement and scheduling solutions to hospitals and other healthcare organisations. We are passionate about using analytics, software and change management to improve quality of care. We pride ourselves on measurable benefit delivery
At ABC Fitness, we're passionate about fitness. We believe that everyone deserves the opportunity to be their best selves and live their best lives. Our technology solutions are designed to empower fitness businesses and individuals to achieve their goals, whether it's building a stronger community, streamlining operations, or providing personalized training experiences. We're committed to making fitness accessible and enjoyable...
ABC Fitness Solutions's Top Stability & Growth Strengths
Strong Market Position & Advantage: Feedback suggests ABC holds a leading position for enterprise gyms and payments at scale, reinforced by multi-platform coverage across operators. External mentions of leadership and large-scale operations indicate durable competitive presence in core segments.
Market Expansion: Feedback suggests ABC has expanded globally with usage in over 100 countries and strengthened regional presence in Latin America via EVO. Partnerships with major franchises and international brands further extend its footprint.
Innovation-Driven Growth: Feedback suggests ongoing product innovation—AI-powered operating infrastructure, new CRM/BI releases, and deeper cross-product integrations—is propelling growth. Regular launches across Ignite, Glofox, Trainerize, and EVO point to a forward-leaning roadmap.
Affidea is a pan-European diagnostic imaging and community-based polyclinic and specialist healthcare services provider, operating in Greece since 2005 to offer high-quality, integrated primary health services.
The Irish Wheelchair Association (IWA) is a leading representative organization and charity in Ireland dedicated to supporting people with physical disabilities. Its mission is to drive positive change by influencing public policy, providing high-quality services—such as assisted living and parking permits—and enabling accessibility to all aspects of society, ensuring people with disabilities enjoy equal rights, choices, and opportunities.
iheed is an online medical education company, built by doctors and healthcare professionals, for doctors and healthcare professionals. iheed designs develops and delivers online university accredited postgraduate education courses in partnership with the world’s leading medical universities that deliver real results for primary care teams worldwide At iheed we believe everyone should have access to a well-educated and highly skilled...
The Avoca Clinic is Ireland’s leading Plastic Surgery Clinic for a reason. Located in multiple discrete locations around the country, you’ll immediately feel the warmth and luxury of our beautifully designed spaces that are home to some of the most technologically advanced equipment and world-class surgeons. Offering the very latest procedures and techniques available to the cosmetic surgery industry, we...
Viatris is a global pharmaceutical company formed in 2020 through the combination of Mylan and Upjohn, a legacy division of Pfizer.
Viatris's Top Stability & Growth Strengths
Cost & Operational Efficiency: Cost-savings efforts are positioned as a concrete lever to support improved earnings and fund growth priorities, with an enterprise-wide program targeting substantial savings over multiple years. Guidance frames these actions as part of a broader move toward sustained revenue and earnings improvement beginning in 2026.
Resilient & Sustainable Growth: Growth is presented as re-emerging, with management guiding to a return to modest year-over-year revenue expansion in 2026 after a softer 2025. Improving quarterly trends exiting 2025 and a baseline of modest operational growth excluding divestitures support a narrative of stabilization.
Strong Market Position & Advantage: Scale and global reach are repeatedly highlighted as a stabilizing advantage, with broad geographic coverage and a large portfolio supporting access, supply reach, and competitive standing in off-patent medicines. The strategic shift toward complex generics and specialty brands is framed as reinforcing the company’s long-term positioning against pricing pressures.
Our mission is to leverage mobile technology, to deliver non-judgemental medical expertise, and the latest therapies to transform the lives of people living with the disease of obesity.
Abi Global Health delivers telemedicine solutions in 37 countries across 6 continents. Our unique artificial intelligence and machine learning technology enables our network of over 1,000 healthcare professionals to provide quick answers to users in 24 languages across a choice of interfaces
At Vertigenius™️, we're pioneering the integration of technology and healthcare to address vestibular disorders, improving balance and reducing dizziness. Our innovative approach includes a clinician portal, a patient app, and a wearable head sensor, making rehabilitation accessible and efficient.
Brennan & Co Group is an Ireland-based supplier and service provider of equipment, reagents, consumables, and supply-chain management. Founded in Dublin, the group serves the Life Sciences, Healthcare, Industrial, and Pharmacy sectors across Ireland, Europe, and Asia. It comprises Brennan & Co and three related companies, combining specialized technological products with servicing and supply-chain expertise for customers in technical and...
Web Summit is a global technology conference company that organizes large-scale events. Its mission is to create software that enables meaningful connections between CEOs, founders, investors, media, politicians, and cultural figureheads who are reshaping the world. The company hosts major events in cities like Lisbon, Rio de Janeiro, Doha, and Vancouver, serving as a premier marketplace for the global tech...
Deciphex is focused on the development of software applications for preclinical/toxicologic pathology that improve productivity and help pathologists focus on the critical content.
For 130 years, Merck, known as MSD outside of the United States and Canada, has been inventing for life, bringing forward medicines and vaccines for many of the world’s most challenging diseases in pursuit of our mission to save and improve lives. We demonstrate our commitment to patients and population health by increasing access to health care through far-reaching policies,...
Merck's Top Stability & Growth Strengths
Strong Market Position & Advantage: Merck holds a clear leadership position, anchored by Keytruda—the world’s top‑selling cancer medicine at $31.7B in 2025—and strong standings in vaccines and overall scale among global pharmas. Animal health also ranks among top players, reinforcing breadth across key healthcare markets.
Innovation-Driven Growth: A broad late‑stage pipeline and scientific presence (100+ ASCO 2026 abstracts across 25+ tumor types) span oncology, vaccines, infectious disease, and cardiometabolic areas. Ongoing label expansions and new formats like subcutaneous Keytruda (including U.S. Keytruda Qlex) are adding growth vectors.
Diversified Revenue Streams: Sales draw from oncology, vaccines (e.g., Gardasil over $10.7B in 2025), hospital acute care, and a growing animal health segment. Newer launches and alliances (e.g., Winrevair, IDVYNSO, and partnered oncology assets) are contributing to mix.
Since our foundation in Dublin, Ireland in 1990, our mission has been to help our clients to accelerate the development of drugs and devices that save lives and improve quality of life. We do this by delivering best in class information, solutions and performance, with an unyielding focus on quality at all times. We offer a full range of consulting, development...
ICON plc's Top Stability & Growth Strengths
Strong Market Position & Advantage: The company is positioned as a top-tier global CRO with significant scale and a broad geographic footprint, supported by a major acquisition that strengthened its competitive standing. Operational activity indicators and industry recognition are presented as reinforcing its ability to win and execute large, complex trials.
Profitability: Earnings and operating profit metrics are described as improving in 2024, with increases in GAAP net income, adjusted earnings per share, and adjusted EBITDA. These results suggest the business maintained solid margin performance even as quarterly revenue fluctuated.
Resilient & Sustainable Growth: A large backlog and a book-to-bill above 1.0 in 2024 are cited as providing multi-year revenue visibility and demand coverage. Continued backlog levels into 2025 are described as a stabilizing factor despite a softer near-term revenue trajectory.
